Zenas Biopharma Inc (ZBIO) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access ZBIO Annual Balance Sheets →
The data below summarizes Zenas Biopharma Inc's balance sheet position from Jun 30 2025 to Jun 30 2026, enabling a period-by-period comparison of financial strength.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent673.90
Short-term Investments, Total923.86
Cash & Short-term Investments1,596.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current10.67
Total Current Assets653.79
Equipment/Property/Plant Net0.02
Long-term investments30.76
Deferred, Prepaid and Other Assets, Noncurrent15.72
Other Assets, Noncurrent1.39
Operating Lease Right Of Use Asset1.09
Total Assets701.69
Liabilities
Accounts Payable, Current AC7.59
Accrued Liabilities, Current AC57.41
Other Liabilities, Current0.82
Total Current Liabilities65.82
Long-term debt297.02
Total Long-term Debt297.02
Other liabilities, Noncurrent91.76
Operating Lease Liability Current1.04
Operating Lease Liability Noncurrent0.08
Royalty Obligation Non Current84.90
Total Liabilities454.59
Stockholders' Equity
Common Stock Value0.01
Additional Paid In Capital Common Stock1,205.80
Retained Earnings / Accumulated Deficit-957.57
Accumulated Other Comprehensive Income-1.14
Other Equity-1.14
Common Stockholder's Equity247.10
Total Stockholder's Equity247.10
Liabilities & Stockholder's Equity701.69
4 historic quarters locked

Sign in to unlock the full Zenas Biopharma Inc balance sheet history.

About Zenas Biopharma Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001104659-26-095448

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License